UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.

Edwards, JC and Szczepanski, L and Szechinski, J and Filipowicz-Sosnowska, A and Emery, P and Close, DR and Stevens, RM and Shaw, T (2004) Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med , 350 (25) 2572 - 2581. 10.1056/NEJMoa032534.

An open access version is available from UCL Discovery

[img]
Preview
PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
105Kb

Abstract

An open-label study indicated that selective depletion of B cells with the use of rituximab led to sustained clinical improvements for patients with rheumatoid arthritis. To confirm these observations, we conducted a randomized, double-blind, controlled study.

Type:Article
Title:Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.
Location:United States
Open access status:An open access version is available from UCL Discovery
DOI:10.1056/NEJMoa032534
Language:English
Keywords:Antibodies, Monoclonal, Antibodies, Monoclonal, Murine-Derived, Antigens, CD20, Antirheumatic Agents, Arthritis, Rheumatoid, B-Lymphocytes, Bacterial Infections, Cyclophosphamide, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Immunosuppressive Agents, Male, Methotrexate, Middle Aged
UCL classification:UCL > School of Life and Medical Sciences > Faculty of Medical Sciences > Medicine (Division of)

View download statistics for this item

Archive Staff Only: edit this record